252
Participants
Start Date
October 31, 2012
Primary Completion Date
June 30, 2016
Study Completion Date
June 30, 2016
OPN-305
Intravenous infusion for 1 hour at start of transplant procedure
Placebo
Intravenous infusion for 1 hour at start of transplant procedure
Research Site, Brussels
Research Site, Leuven
Research Site, Rotterdam
Research Site, Liège
Research Site, Nijmegen
Research Site, Zurich
Research Site, Ghent
Research Site, Groningen
Research Site, New York
Research Site, Berlin
Research Site, The Bronx
Research Site, Berlin
Research Site, Prague
Research Site, Harrisburg
Research Site, Washington D.C.
Research Site, Richmond
Research Site, Madrid
Research Site, Charleston
Research Site, Toulouse
Research Site, Bordeaux
Research Site, Tampa
Research Site, Santander
Research Site, Bochum
Research Site, Münster
Research Site, Cologne
Research Site, Bonn
Research Site, Chicago
Research Site, Mannheim
Research Site, Heidelberg
Research Site, New Orleans
Research Site, New Orleans
Research Site, Tübingen
Research Site, Dallas
Research Site, Paris
Research Site, Fort Worth
Research Site, Los Angeles
Research Site, Erlangen
Research Site, Livingston
Research Site, Linz
Research Site, Leiden
Research Site, Bydgoszcz
Research Site, Lodz
Research Site, Szczecin
Research Site, Warsaw
Research Site, Warsaw
Research Site, Barcelona
Research Site, Barcelona
Research Site, Barcelona
Research Site, London
Research Site, Newcastle upon Tyne
Lead Sponsor
Opsona Therapeutics Ltd.
INDUSTRY